Its stock is up 50 percent. Billion-dollar deals for breakfast. How did Boston Scientific get its mojo back?
The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...
medtechdive2d
Boston Scientific resumes PFA trial in new patient group after pausing enrollment
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
FierceBiotech10d
Boston Scientific bolsters pulsed field ablation business with Cortex buy
As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...
Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
Seeking Alpha22d
Boston Sci stock falls 4% amid FARAPULSE study update
Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a study for its new FARAPULSE Pulse Field Ablation system due to unforeseen ...
Reuters22d
Boston Scientific lifts annual profit forecast, pauses heart device study
Massachusetts-based Boston Scientific generates most of its revenue from sales of its heart devices, such as pacemakers and stents. It also makes equipment to diagnose and treat a range of ...
The Business Journals22d
Boston Scientific stock sinks on atrial fibrillation trial pause
Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...